Per Falholt on innovation
Business performance See all
Per Falholt on innovation
03:54Per Falholt discusses the cost approach in Novozymes' Research and Development and radical innovation.
Related
Welcome to Novozymes China
04:46
|
Just another day at the office ...
05:26
|
"We have to make sure that if we succeed the up-sides are big.”
04:03
|
Financial results 2010
05:00
|
”What is limiting us is only our own creativity"
02:30
|
"The opportunities we’re looking at are escalating as we speak.”
04:50
|
"Jointly with our customers we solve the ideas they come up with."
03:33
|
”We’re able to invest even further in our business in the future.”
03:33
|
Novozymes acquires EMD/Merck Crop BioScience
04:22
|
Thomas Videbæk on Q1 2010
05:42
|
Thomas Videbæk on biotechnology
04:34
|
Thomas Nagy on sustainability
04:33
|
Peder Holk Nielsen on the development in Enzyme Business
04:19
|
Steen Riisgaard on the outlook for 2010
03:46
|
CFO Benny Loft on the overall results for the year
04:14
|
Benny Loft, CFO, Novozymes on Q3 results
04:31
|
Raising the bar for a good dough
03:38
|
Financial results 2011: Perspectives from Executive Management
03:52
|
Ulla Matthiesen
Kenneth Aukdal